Therapeutic application of EUS-guided intraportal autologous bone marrow transplantation for decompensated liver cirrhosis.

Stem Cell Res Ther · 2025 · PMC12587643 · PMID 41194261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Comparing the changes in routine blood tests before and after treatment (Supplementary Figure S1), the increase of WBC and HGB in the EUS-POV group at 1 month after ABMT was significantly different from that of the conventional treatment group ( P < 0.05), while the WBC and HGB in the PEV group showed a trend of increase but were not statistically significant compared with that of the conventional treatment group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.